 |
|
|
|||||
Indian pharmaceutical companies are set for a steady September quarter. Growth in the US generics market and domestic sales will drive performance. Companies like Apollo Hospitals, Lupin, and Aurobindo are expected to show strong results. Despite some cost pressures, the sector anticipates positive medium-term prospects. New product launches and expanding facilities will support earnings.
Category:
News and Media
Nifty eyes further upside, potentially crossing 25,45025,500, with banking and consumption stocks showing promise. Analysts suggest Nifty should sustain above 24,900, while a move past 25,440 could target 25,700. Investors are advised to look for opportunities in sectors like banking, auto, metal, and consumption.
Category:
News and Media
Investors are rushing to buy Sovereign Gold Bonds in the secondary market. They are paying prices much higher than gold's current value. This buying spree is driven by perceived benefits like annual interest and tax-free gains. However, these investors face potential losses if gold prices decline. The limited supply of these bonds is also contributing to the price surge.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||